These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36018286)

  • 1. VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK.
    Priyanka P; Chang CH; Chawla LS; Kellum JA; Clermont G; Murugan R
    Shock; 2022 Oct; 58(4):260-268. PubMed ID: 36018286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced exposure to vasopressors through permissive hypotension to reduce mortality in critically ill people aged 65 and over: the 65 RCT.
    Mouncey PR; Richards-Belle A; Thomas K; Harrison DA; Sadique MZ; Grieve RD; Camsooksai J; Darnell R; Gordon AC; Henry D; Hudson N; Mason AJ; Saull M; Whitman C; Young JD; Lamontagne F; Rowan KM;
    Health Technol Assess; 2021 Feb; 25(14):1-90. PubMed ID: 33648623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative Hypotension and Adverse Kidney-related Outcomes among Critically Ill Patients with Shock. A Multicenter, Prospective Cohort Study.
    Panwar R; Tarvade S; Lanyon N; Saxena M; Bush D; Hardie M; Attia J; Bellomo R; Van Haren F;
    Am J Respir Crit Care Med; 2020 Nov; 202(10):1407-1418. PubMed ID: 32614244
    [No Abstract]   [Full Text] [Related]  

  • 4. A PILOT STUDY OF ANGIOTENSIN II AS PRIMARY VASOPRESSOR IN CRITICALLY ILL ADULTS WITH VASODILATORY HYPOTENSION: THE ARAMIS STUDY.
    See EJ; Clapham C; Liu J; Khasin M; Liskaser G; Chan JW; Serpa Neto A; Costa Pinto R; Bellomo R
    Shock; 2023 May; 59(5):691-696. PubMed ID: 36930693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Vasopressor Utilization Strategies and Outcomes in Critically Ill Patients With Severe Traumatic Brain Injury.
    Toro C; Ohnuma T; Komisarow J; Vavilala MS; Laskowitz DT; James ML; Mathew JP; Hernandez AF; Goldstein BA; Sampson JH; Krishnamoorthy V
    Anesth Analg; 2022 Dec; 135(6):1245-1252. PubMed ID: 35203085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study.
    Subramanian S; Yilmaz M; Rehman A; Hubmayr RD; Afessa B; Gajic O
    Intensive Care Med; 2008 Jan; 34(1):157-62. PubMed ID: 17924093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoepidemiology of metaraminol in critically ill patients with shock in a tertiary care hospital.
    Sardaneh AA; Penm J; Oliver M; Gattas D; McLachlan AJ; Patanwala AE
    Aust Crit Care; 2021 Nov; 34(6):573-579. PubMed ID: 33663948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock.
    Roberts RJ; Miano TA; Hammond DA; Patel GP; Chen JT; Phillips KM; Lopez N; Kashani K; Qadir N; Cairns CB; Mathews K; Park P; Khan A; Gilmore JF; Brown ART; Tsuei B; Handzel M; Chang AL; Duggal A; Lanspa M; Herbert JT; Martinez A; Tonna J; Ammar MA; Nazer LH; Heavner M; Pender E; Chambers L; Kenes MT; Kaufman D; Downey A; Brown B; Chaykosky D; Wolff A; Smith M; Nault K; Gong MN; Sevransky JE; Lat I;
    Crit Care Med; 2020 Oct; 48(10):1445-1453. PubMed ID: 32706559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial.
    Lamontagne F; Meade MO; Hébert PC; Asfar P; Lauzier F; Seely AJE; Day AG; Mehta S; Muscedere J; Bagshaw SM; Ferguson ND; Cook DJ; Kanji S; Turgeon AF; Herridge MS; Subramanian S; Lacroix J; Adhikari NKJ; Scales DC; Fox-Robichaud A; Skrobik Y; Whitlock RP; Green RS; Koo KKY; Tanguay T; Magder S; Heyland DK;
    Intensive Care Med; 2016 Apr; 42(4):542-550. PubMed ID: 26891677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial.
    Lamontagne F; Richards-Belle A; Thomas K; Harrison DA; Sadique MZ; Grieve RD; Camsooksai J; Darnell R; Gordon AC; Henry D; Hudson N; Mason AJ; Saull M; Whitman C; Young JD; Rowan KM; Mouncey PR;
    JAMA; 2020 Mar; 323(10):938-949. PubMed ID: 32049269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes Associated With Norepinephrine Use Among Cardiac Intensive Care Unit Patients with Severe Shock.
    Burstein B; Vallabhajosyula S; Ternus B; Murphree D; Barsness GW; Kashani K; Jentzer JC
    Shock; 2021 Oct; 56(4):522-528. PubMed ID: 34524266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-Line Vasopressor Use in Septic Shock and Route of Administration: An Epidemiologic Study.
    Teja B; Bosch NA; Wijeysundera DN; Wijeysundera HC; Saskin R; Hill AD; Stelfox HT; Walkey AJ; Wunsch H
    Ann Am Thorac Soc; 2022 Oct; 19(10):1713-1721. PubMed ID: 35709214
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
    Shankar-Hari M; Phillips GS; Levy ML; Seymour CW; Liu VX; Deutschman CS; Angus DC; Rubenfeld GD; Singer M;
    JAMA; 2016 Feb; 315(8):775-87. PubMed ID: 26903336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The order of vasopressor discontinuation and incidence of hypotension: a retrospective cohort analysis.
    Song X; Liu X; Evans KD; Frank RD; Barreto EF; Dong Y; Liu C; Gao X; Wang C; Kashani KB
    Sci Rep; 2021 Aug; 11(1):16680. PubMed ID: 34404892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of parameters associated with hypotension requiring vasopressor support after carotid angioplasty and stenting.
    Trocciola SM; Chaer RA; Lin SC; Ryer EJ; De Rubertis B; Morrissey NJ; McKinsey J; Kent KC; Faries PL
    J Vasc Surg; 2006 Apr; 43(4):714-20. PubMed ID: 16616226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of diuretics in shock: Temporal trends and clinical impacts in a propensity-matched cohort study.
    Bandak G; Sakhuja A; Andrijasevic NM; Gunderson TM; Gajic O; Kashani K
    PLoS One; 2020; 15(2):e0228274. PubMed ID: 32053637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and Outcomes of Peripheral Vasopressors in Early Sepsis-Induced Hypotension Across Michigan Hospitals: A Retrospective Cohort Study.
    Munroe ES; Heath ME; Eteer M; Gershengorn HB; Horowitz JK; Jones J; Kaatz S; Tamae Kakazu M; McLaughlin E; Flanders SA; Prescott HC
    Chest; 2024 Apr; 165(4):847-857. PubMed ID: 37898185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.
    Chotalia M; Matthews T; Arunkumar S; Bangash MN; Parekh D; Patel JM
    Anaesthesia; 2021 Oct; 76(10):1358-1366. PubMed ID: 33687732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.